These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17893003)

  • 1. Infarct size, ejection fraction, and mortality in diabetic patients with acute myocardial infarction treated with thrombolytic therapy.
    Alegria JR; Miller TD; Gibbons RJ; Yi QL; Yusuf S;
    Am Heart J; 2007 Oct; 154(4):743-50. PubMed ID: 17893003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Larger infarct size and lower left ventricular ejection fraction (LVEF) contribute to the higher mortality in diabetic patients with ST elevation myocardial infarction.
    Ramaraj R
    Am Heart J; 2008 Mar; 155(3):e27. PubMed ID: 18294470
    [No Abstract]   [Full Text] [Related]  

  • 3. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.
    Ezekowitz JA; Armstrong PW; Granger CB; Theroux P; Stebbins A; Kim RJ; Patel MR
    Am Heart J; 2010 Aug; 160(2):272-8. PubMed ID: 20691832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial.
    Patel MR; Worthley SG; Stebbins A; Dill T; Rademakers FE; Valeti US; Barsness GW; Van de Werf F; Hamm CW; Armstrong PW; Granger CB; Kim RJ
    JACC Cardiovasc Imaging; 2010 Jan; 3(1):52-60. PubMed ID: 20129531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ST-segment analysis to predict infarct size and functional outcome in acute myocardial infarction treated with primary coronary intervention and adjunctive abciximab therapy.
    Sciagrà R; Parodi G; Migliorini A; Valenti R; Antoniucci D; Sotgia B; Pupi A
    Am J Cardiol; 2006 Jan; 97(1):48-54. PubMed ID: 16377283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction.
    Pride YB; Appelbaum E; Lord EE; Sloan S; Cannon CP; Sabatine MS; Gibson CM;
    Am J Cardiol; 2009 Aug; 104(4):475-9. PubMed ID: 19660597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of initial infarct size to extent of left ventricular remodeling in the year after acute myocardial infarction.
    Chareonthaitawee P; Christian TF; Hirose K; Gibbons RJ; Rumberger JA
    J Am Coll Cardiol; 1995 Mar; 25(3):567-73. PubMed ID: 7860898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial).
    Marso SP; Miller T; Rutherford BD; Gibbons RJ; Qureshi M; Kalynych A; Turco M; Schultheiss HP; Mehran R; Krucoff MW; Lansky AJ; Stone GW
    Am J Cardiol; 2007 Jul; 100(2):206-10. PubMed ID: 17631071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predischarge electrocardiographic pattern in anterior acute myocardial infarction: relation between evolutionary ST segment and T-wave configuration and prediction of myocardial infarct size and left ventricular systolic function by the QRS Selvester score.
    Birnbaum Y; Strasberg B
    J Electrocardiol; 2000; 33 Suppl():73-80. PubMed ID: 11265740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial.
    Timmer JR; Ottervanger JP; de Boer MJ; Boersma E; Grines CL; Westerhout CM; Simes RJ; Granger CB; Zijlstra F;
    Arch Intern Med; 2007 Jul; 167(13):1353-9. PubMed ID: 17620527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of dobutamine echocardiography and 99mTc-sestamibi tomography for prediction of left ventricular ejection fraction outcome after acute myocardial infarction treated with successful primary coronary angioplasty.
    Sciagrà R; Sestini S; Bolognese L; Cerisano G; Buonamici P; Pupi A
    J Nucl Med; 2002 Jan; 43(1):8-14. PubMed ID: 11801696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infarct size determination by technetium 99m sestamibi single-photon emission computed tomography predicts survival in patients with chronic coronary artery disease.
    Hurrell DG; Milavetz J; Hodge DO; Gibbons RJ
    Am Heart J; 2000 Jul; 140(1):61-6. PubMed ID: 10874264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective identification of myocardial stunning using technetium-99m sestamibi-based measurements of infarct size.
    Christian TF; Gitter MJ; Miller TD; Gibbons RJ
    J Am Coll Cardiol; 1997 Dec; 30(7):1633-40. PubMed ID: 9385887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics, left and right ventricular ejection fraction, and long-term prognosis in patients with non-insulin-dependent diabetes surviving an acute myocardial infarction.
    Melchior T; Gadsbøll N; Hildebrandt P; Køber L; Torp-Pedersen C
    Diabet Med; 1996 May; 13(5):450-6. PubMed ID: 8737027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of serial measurements of infarct size and left ventricular ejection fraction by contrast-enhanced cardiac magnetic resonance imaging and electrocardiographic QRS scoring in reperfused anterior ST-elevation myocardial infarction.
    Weir RA; Martin TN; Murphy CA; Petrie CJ; Clements S; Steedman T; Dargie HJ; Wagner GS
    J Electrocardiol; 2010; 43(3):230-6. PubMed ID: 20116803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased left ventricular dysfunction in elderly patients despite successful thrombolysis: the GUSTO-I angiographic experience.
    Lesnefsky EJ; Lundergan CF; Hodgson JM; Nair R; Reiner JS; Greenhouse SW; Califf RM; Ross AM
    J Am Coll Cardiol; 1996 Aug; 28(2):331-7. PubMed ID: 8800106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis.
    Burns RJ; Gibbons RJ; Yi Q; Roberts RS; Miller TD; Schaer GL; Anderson JL; Yusuf S;
    J Am Coll Cardiol; 2002 Jan; 39(1):30-6. PubMed ID: 11755283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of left ventricular ejection fraction and its relationship to infarct size after acute myocardial infarction.
    Ndrepepa G; Mehilli J; Martinoff S; Schwaiger M; Schömig A; Kastrati A
    J Am Coll Cardiol; 2007 Jul; 50(2):149-56. PubMed ID: 17616299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Late thrombolysis in acute myocardial infarct. Demonstration of myocardial tissue salvage by the assessment of pre- and post-thrombolytic perfusion and left ventricular function].
    Leoncini M; Marcucci G; Santoro GM; Sciagrà R; Bini L; Bisi G; Silvestri M; Paterni M; Icardi G; Mennuti A
    G Ital Cardiol; 1994 Nov; 24(11):1359-70. PubMed ID: 7828789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mismatch index based on the difference between measured left ventricular ejection fraction and that estimated by infarct size at three months following reperfused acute myocardial infarction.
    Carlsen EA; Bang LE; Lønborg J; Ahtarovski KA; Køber L; Kelbæk H; Vejlstrup N; Jørgensen E; Helqvist S; Saunamäki K; Clemmensen P; Holmvang L; Wagner GS; Engstrøm T
    J Electrocardiol; 2014; 47(2):191-6. PubMed ID: 24373864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.